Woodworth Graeme F, Chaichana Kaisorn L, McGirt Matthew J, Sciubba Daniel M, Jallo George I, Gokaslan Ziya, Wolinsky Jean-Paul, Witham Timothy F
Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, Maryland 21287, USA.
Neurosurgery. 2007 Jul;61(1):99-105; discussion 105-6. doi: 10.1227/01.neu.0000279729.36392.42.
Contemporary treatment of intramedullary spinal cord tumors (IMSCTs) involves radical or subtotal tumor resection with adjuvant radiation and/or chemotherapy, depending on the tumor's histological type and grade as well as the extent of resection. Despite advances in surgical therapy, this approach continues to have significant morbidity. Although previous research is limited, identifying reliable predictors of functional status after tumor resection would be clinically useful for perioperative modification strategies.
All patients who underwent surgery for IMSCTs at an academic tertiary care institution between 1995 and 2004 were retrospectively reviewed, and predictors of postoperative neurological functional status were assessed by multivariate logistical regression analysis. Neurological status was gauged by the ability to walk without assistance at the time of the last follow-up visit.
Seventy-eight IMSCT resections were performed during the study period. Preoperative (on the day of or the day before surgery) serum glucose greater than 170 mg/dl (relative risk, 0.03; 95% confidence interval, 0.00-0.27; P = 0.001) and preoperative radiation therapy (relative risk, 0.02; 95% confidence interval, 0.00-0.39, P = 0.012) were independently associated with poor functional status postoperatively. The ability to walk unassisted before surgery (relative risk, 17.1; 95% confidence interval, 1.89-154.5, P = 0.012), on other hand, was the only positive predictor of the ability to walk unassisted at the time of the last follow-up visit.
This study suggests that early surgical intervention after the onset of symptoms for patients with IMSCT may help preserve ambulatory function. Deferral of preoperative radiation therapy for less radiosensitive tumors and strict perioperative glucose control may also help maximize a patient's subsequent ambulatory status.
当代髓内脊髓肿瘤(IMSCTs)的治疗包括根据肿瘤的组织学类型、分级以及切除范围,进行根治性或次全肿瘤切除,并辅以放疗和/或化疗。尽管手术治疗取得了进展,但这种方法仍有显著的发病率。虽然先前的研究有限,但确定肿瘤切除后功能状态的可靠预测因素对于围手术期的调整策略在临床上将是有用的。
对1995年至2004年间在一家学术性三级医疗机构接受IMSCTs手术的所有患者进行回顾性研究,并通过多因素逻辑回归分析评估术后神经功能状态的预测因素。神经功能状态通过最后一次随访时无需辅助行走的能力来衡量。
在研究期间共进行了78例IMSCTs切除手术。术前(手术当天或前一天)血清葡萄糖大于170mg/dl(相对风险,0.03;95%置信区间,0.00 - 0.27;P = 0.001)和术前放疗(相对风险,0.02;95%置信区间,0.00 - 0.39,P = 0.012)与术后功能状态不佳独立相关。另一方面,术前无需辅助行走的能力(相对风险,17.1;95%置信区间,1.89 - 154.5,P = 0.012)是最后一次随访时无需辅助行走能力的唯一正向预测因素。
本研究表明,IMSCT患者症状出现后尽早进行手术干预可能有助于保留行走功能。对于放射敏感性较低的肿瘤推迟术前放疗以及严格的围手术期血糖控制也可能有助于使患者随后的行走状态达到最佳